These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15362030)

  • 1. A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer.
    Bresalier RS; Byrd JC; Tessler D; Lebel J; Koomen J; Hawke D; Half E; Liu KF; Mazurek N;
    Gastroenterology; 2004 Sep; 127(3):741-8. PubMed ID: 15362030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
    Bresalier RS; Byrd JC; Wang L; Raz A
    Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
    Ohannesian DW; Lotan D; Lotan R
    Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon cancer.
    Dudas SP; Yunker CK; Sternberg LR; Byrd JC; Bresalier RS
    Gastroenterology; 2002 Sep; 123(3):817-26. PubMed ID: 12198708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.
    Carlsson MC; Cederfur C; Schaar V; Balog CI; Lepur A; Touret F; Salomonsson E; Deelder AM; Fernö M; Olsson H; Wuhrer M; Leffler H
    PLoS One; 2011; 6(10):e26560. PubMed ID: 22028908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.
    Nagy N; Bronckart Y; Camby I; Legendre H; Lahm H; Kaltner H; Hadari Y; Van Ham P; Yeaton P; Pector JC; Zick Y; Salmon I; Danguy A; Kiss R; Gabius HJ
    Gut; 2002 Mar; 50(3):392-401. PubMed ID: 11839721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects.
    Park SY; Yoon SJ; Jeong YT; Kim JM; Kim JY; Bernert B; Ullman T; Itzkowitz SH; Kim JH; Hakomori SI
    Int J Cancer; 2010 Jan; 126(1):142-55. PubMed ID: 19551866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions.
    Greco C; Vona R; Cosimelli M; Matarrese P; Straface E; Scordati P; Giannarelli D; Casale V; Assisi D; Mottolese M; Moles A; Malorni W
    Glycobiology; 2004 Sep; 14(9):783-92. PubMed ID: 15140826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.
    Ulmer TA; Keeler V; Loh L; Chibbar R; Torlakovic E; André S; Gabius HJ; Laferté S
    J Cell Biochem; 2006 Aug; 98(5):1351-66. PubMed ID: 16518858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.
    Huang Z; Ai Z; Li N; Xi H; Gao X; Wang F; Tan X; Liu H
    Cancer Biomark; 2016; 17(4):445-455. PubMed ID: 28085015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 88-kDa Eales' protein in serum is a complex of haptoglobin, complement C3, and galectin-1 as identified by liquid chromatography coupled mass spectrometry.
    Ramanujam S; Muthuvel B; Aravind C B; Biswas J; Konerirajapuram NS
    Proteomics Clin Appl; 2017 Jan; 11(1-2):. PubMed ID: 27739660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands.
    Mazurek N; Conklin J; Byrd JC; Raz A; Bresalier RS
    J Biol Chem; 2000 Nov; 275(46):36311-5. PubMed ID: 10961987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors.
    Išić T; Savin S; Cvejić D; Marečko I; Tatić S; Havelka M; Paunović I
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1805-12. PubMed ID: 20204403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.
    Ohannesian DW; Lotan D; Thomas P; Jessup JM; Fukuda M; Gabius HJ; Lotan R
    Cancer Res; 1995 May; 55(10):2191-9. PubMed ID: 7743523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
    Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
    Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression.
    Sanjuán X; Fernández PL; Castells A; Castronovo V; van den Brule F; Liu FT; Cardesa A; Campo E
    Gastroenterology; 1997 Dec; 113(6):1906-15. PubMed ID: 9394730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semen.
    Block AS; Saraswati S; Lichti CF; Mahadevan M; Diekman AB
    Prostate; 2011 May; 71(7):711-21. PubMed ID: 21031433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.
    Wu KL; Chen HH; Pen CT; Yeh WL; Huang EY; Hsiao CC; Yang KD
    Biomed Res Int; 2015; 2015():306964. PubMed ID: 26448934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum MicroRNA profile in patients with colon adenomas or cancer.
    Zhang Y; Li M; Ding Y; Fan Z; Zhang J; Zhang H; Jiang B; Zhu Y
    BMC Med Genomics; 2017 Apr; 10(1):23. PubMed ID: 28427387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon.
    Schoeppner HL; Raz A; Ho SB; Bresalier RS
    Cancer; 1995 Jun; 75(12):2818-26. PubMed ID: 7773932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.